1. Home
  2. AFBI vs NMRA Comparison

AFBI vs NMRA Comparison

Compare AFBI & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFBI
  • NMRA
  • Stock Information
  • Founded
  • AFBI 1928
  • NMRA 2019
  • Country
  • AFBI United States
  • NMRA United States
  • Employees
  • AFBI N/A
  • NMRA N/A
  • Industry
  • AFBI Major Banks
  • NMRA
  • Sector
  • AFBI Finance
  • NMRA
  • Exchange
  • AFBI Nasdaq
  • NMRA Nasdaq
  • Market Cap
  • AFBI 117.0M
  • NMRA 121.0M
  • IPO Year
  • AFBI N/A
  • NMRA 2023
  • Fundamental
  • Price
  • AFBI $18.69
  • NMRA $0.80
  • Analyst Decision
  • AFBI
  • NMRA Buy
  • Analyst Count
  • AFBI 0
  • NMRA 8
  • Target Price
  • AFBI N/A
  • NMRA $9.29
  • AVG Volume (30 Days)
  • AFBI 4.3K
  • NMRA 1.3M
  • Earning Date
  • AFBI 07-25-2025
  • NMRA 08-05-2025
  • Dividend Yield
  • AFBI 8.05%
  • NMRA N/A
  • EPS Growth
  • AFBI N/A
  • NMRA N/A
  • EPS
  • AFBI 0.91
  • NMRA N/A
  • Revenue
  • AFBI $31,043,000.00
  • NMRA N/A
  • Revenue This Year
  • AFBI N/A
  • NMRA N/A
  • Revenue Next Year
  • AFBI N/A
  • NMRA N/A
  • P/E Ratio
  • AFBI $20.49
  • NMRA N/A
  • Revenue Growth
  • AFBI 4.89
  • NMRA N/A
  • 52 Week Low
  • AFBI $17.00
  • NMRA $0.61
  • 52 Week High
  • AFBI $22.50
  • NMRA $17.19
  • Technical
  • Relative Strength Index (RSI)
  • AFBI 50.32
  • NMRA 44.07
  • Support Level
  • AFBI $18.36
  • NMRA $0.72
  • Resistance Level
  • AFBI $18.70
  • NMRA $0.85
  • Average True Range (ATR)
  • AFBI 0.17
  • NMRA 0.07
  • MACD
  • AFBI 0.02
  • NMRA -0.02
  • Stochastic Oscillator
  • AFBI 29.82
  • NMRA 8.08

About AFBI Affinity Bancshares Inc. (MD)

Affinity Bancshares Inc is a holding company of Affinity Bank, a federally chartered stock savings bank that offers a variety of deposit accounts, including checking accounts, savings accounts, and certificate of deposit accounts. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate loans, commercial and industrial loans, residential real estate loans, construction and land loans, and consumer loans. It also invests in securities, which consist of mortgage-backed securities and obligations issued by United States government-sponsored enterprises and Federal Home Loan Bank stock.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Share on Social Networks: